Ana María
López González
Hospital Universitario de la Princesa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (2)
2019
-
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study
Breast Journal, Vol. 25, Núm. 2, pp. 219-225
2014
-
Aldehyde dehydrogenases in early stage lung cancer: nuclear expression
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 931-934